In contrast, the same dosage of free DxM-P (3 × 1 mg/kg) only transiently reduced the arthritis score by 51% and the paw volume by 65%, with a strong rebound starting two days after the end of therapy (Figure 1a, b; Table 1). This evidence concerns the gene OCA2 and arthritic joint disease.